Bellecapital International Q2 Portfolio Shifts: Focus on Tech and Financial Services
Bellecapital International Ltd. significantly reshaped its portfolio during Q2 2026, increasing allocations in key sectors while exiting some positions.
According to the latest filing from Bellecapital International Ltd., the investment firm's portfolio underwent substantial changes during Q2 2026. The total portfolio value remained steady at $616,755,645 as of June 30th, but there were notable shifts in individual holdings and sector allocations compared to prior periods.
Prominent Purchases: Technology Giants & Financial Services
Bellecapital International demonstrated a clear preference for growth during this quarter. The firm significantly increased its position in Booking Holdings Inc. (BKNG), adding 93,995 shares and boosting the stake by approximately 276%. This substantial increase suggests confidence in the travel technology sector's prospects. Similarly, a major purchase was recorded for Ferrari N.V. (RACE), with the firm acquiring shares representing an entirely new position or significantly increasing an existing one by 100%, adding substantial value to its portfolio allocation of about $14 million.
The investment strategy also saw significant inflows into Brookfield Corp. (BN), where Bellecapital added 339,979 shares, resulting in a nearly fivefold increase or over 5,500% growth. This move substantially boosted the allocation to this stock and its sector. Furthermore, Ryan Specialty Holdings Inc. (RYAN) experienced a full acquisition by Bellecapital during Q2 2026, adding a new position with an allocation of $11 million or about 1.84% of the portfolio.
Growth in Tech and International Exposure
The Technology sector saw two major additions from Bellecapital this quarter. The firm significantly bolstered its stake in Apple Inc. (AAPL), adding 3,747 shares and increasing the allocation by roughly $1 million to reach approximately $5.3% of the portfolio value. This was part of a broader trend in Technology holdings, which also included a substantial increase in Meta Platforms Inc. (META), adding shares that increased its allocation by about 67% to nearly $4 million invested. The firm also added new positions within Technology, including the highly anticipated addition of Xometry Inc. (XMTR), which saw a significant increase in its portfolio allocation despite being outside the top holdings list previously.
Sales and Reductions: Exiting Certain Positions
Bellecapital International also engaged in strategic sales during Q2 2026. The firm sold shares of Alphabet Inc. (GOOGL), reducing its allocation by approximately $1 million due to a nearly 12% decrease in the number of shares held. Similarly, there was a significant reduction in holdings for Taiwan Semiconductor Manufacturing Co. (TSM), with a roughly $30 million decrease attributed to an almost 29% drop in the number of shares. The firm also partially divested from its position in Pfizer Inc. (PFE), although this was not a complete exit, as indicated by the change percentages and share counts provided.
Mixed Signals: Minor Changes & Unknown Sectors
The portfolio changes also included minor adjustments. For instance, Xometry Inc. (XMTR) experienced a decrease in its position by 15%, while the firm added shares to Ferrari N.V. (RACE), which was already noted as a significant buy. The allocation for Brookfield Corp. (BN) saw an increase, while the position in Ryan Specialty Holdings Inc. (RYAN), which was a full acquisition this quarter, also increased. Notably, there were no disclosed purchases or sales within the Healthcare sector except for adjustments to existing positions like Pfizer. The firm's portfolio still includes assets classified under 'Unknown' sectors.
Overall Strategy: Diversification and Focus on Growth
Bellecapital International appears to be actively managing its $617 million portfolio, focusing on diversifying into different growth areas while strategically reducing exposure in others. The quarter featured significant buying activity across various sectors including Technology (Apple, Meta, Xometry), Consumer Cyclical (Booking Holdings), and Financial Services (Brookfield Corp., Ryan Specialty). Conversely, the firm also sold substantial portions of its holdings in Alphabet and TSM. The overall portfolio allocation shows a continued diversification effort, with Technology remaining the largest sector at 30.67%, followed by Communication Services (12.26%), Healthcare (9.28%), Consumer Cyclical (8.62%), and Financial Services (6.88%).